Klaus Liefeith | Medicine and Dentistry | Best Researcher Award

Published on by Cognitive Scientist Awards

Best Researcher Award

Klaus Liefeith
Researcher Klaus Liefeith
Affiliation Institute for Bioprocessing and Analytical Measurement Techniques e.V.
Country Germany
Scopus ID 6602970287
Documents 95
Citations 1811
h-index 21
Subject Area Medicine and Dentistry
Event International Cognitive Scientists Award
ORCID 0000-0002-8122-4481

Klaus Liefeith
Institute for Bioprocessing and Analytical Measurement Techniques e.V.

Klaus Liefeith is a German researcher affiliated with the Institute for Bioprocessing and Analytical Measurement Techniques e.V. and is recognized for his scientific contributions within the fields of biomaterials, regenerative medicine, tissue engineering, and biomedical technologies. His scholarly work has contributed to the advancement of translational medical research, particularly through the development of innovative materials and analytical approaches designed to support healthcare applications. Based on publication records indexed in Scopus, his research output demonstrates sustained academic productivity and measurable scholarly influence through citations and collaborative scientific engagement.[1]

Abstract

This article presents an academic overview of Klaus Liefeith and his research achievements in the areas of biomaterials, biomedical engineering, regenerative medicine, and applied medical sciences. Through a documented publication record consisting of 95 indexed documents and more than 1,800 citations, Liefeith has contributed to scientific understanding in areas associated with tissue regeneration, medical devices, biofunctional materials, and analytical measurement technologies. His research portfolio reflects interdisciplinary collaboration and sustained scholarly activity that supports innovation in healthcare and medical research.[1]

Keywords

Biomaterials, Regenerative Medicine, Tissue Engineering, Biomedical Engineering, Medical Devices, Analytical Measurement Techniques, Translational Research, Medicine and Dentistry, Research Impact, Scientific Innovation.

Introduction

The advancement of modern healthcare increasingly depends on interdisciplinary scientific research that combines biological sciences, engineering principles, and material innovations. Researchers operating at the interface of these disciplines play a significant role in developing technologies that improve diagnostic, therapeutic, and regenerative medical practices. His research activities are associated with the translation of laboratory discoveries into practical healthcare solutions, contributing to broader scientific progress in medicine and dentistry.[2]

Research Profile

Liefeith’s professional profile demonstrates sustained involvement in applied biomedical research. Working within the Institute for Bioprocessing and Analytical Measurement Techniques e.V., His work reflects an interdisciplinary approach that integrates engineering concepts with biological systems to address contemporary healthcare challenges. The diversity of his publication record illustrates active participation in international scientific discussions and collaborative research networks.[1]

Research Contributions

  • Development and characterization of biomaterials suitable for biomedical and regenerative applications.
  • Research on tissue engineering scaffolds designed to support cellular growth and tissue regeneration.
  • Contributions to analytical measurement techniques relevant to biological and medical investigations.
  • Investigation of biofunctional surfaces intended to improve interactions between materials and biological systems.
  • Participation in collaborative studies supporting translational medicine and healthcare innovation.[3]

Publications

According to available indexing databases, Klaus Liefeith has authored and co-authored numerous peer-reviewed publications across biomedical and materials science disciplines. His publication record includes articles examining biomaterials, tissue engineering constructs, regenerative therapies, analytical technologies, and biomedical surface modifications. These publications have been disseminated through international scientific journals and conference proceedings, facilitating knowledge exchange within the global research community.[1]

Research Impact

Research impact may be assessed through scholarly indicators including publication volume, citation frequency, and h-index performance. With 95 indexed documents, 1,811 citations, and an h-index of 21, Liefeith’s academic record demonstrates sustained visibility within the scientific literature. These indicators suggest that his work has been referenced by researchers across multiple disciplines and continues to contribute to ongoing scientific investigations. Citation activity further reflects the relevance of his research outputs to current developments in biomedical science and healthcare innovation.[1]

Award Suitability

The Best Researcher Award recognizes sustained scientific excellence, impactful scholarship, and meaningful contributions to academic advancement. Klaus Liefeith’s publication portfolio, citation record, interdisciplinary research engagement, and contributions to biomedical innovation align with several criteria commonly associated with distinguished research recognition. His work demonstrates continued commitment to scientific inquiry and practical healthcare applications, supporting the objectives of the International Cognitive Scientists Award program.[1][4]

Conclusion

Klaus Liefeith represents an established contributor to biomedical and regenerative medicine research. Through extensive scholarly activity, interdisciplinary collaboration, and the development of innovative biomaterial solutions, he has participated in advancing scientific knowledge relevant to healthcare and medical technology. His documented publication and citation record, together with his contributions to translational biomedical research, provide a foundation supporting recognition within the Best Researcher Award category. Continued engagement in scientific investigation is expected to further contribute to the evolution of biomedical sciences and related healthcare applications.[1]

References

  1. Elsevier. (n.d.). Scopus author details: Klaus Liefeith, Author ID 6602970287. Scopus.
    https://www.scopus.com/authid/detail.uri?authorId=6602970287
  2. ORCID. (n.d.). Klaus Liefeith Research Profile.
    https://orcid.org/0000-0002-8122-4481
  3. Liefeith, K. et al. Research in biomaterials and regenerative medicine.
    DOI: https://doi.org/10.1016/j.actbio.2012.07.017
  4. International Cognitive Scientists Award. (n.d.). Award Information and Recognition Criteria.
    https://cognitivescientist.org/

Md Jannatul Islam Polash | Drug Design | Research Excellence Award

Published on by Cognitive Scientist Awards

Mr. Md Jannatul Islam Polash | Drug Design | Research Excellence Award

Islamic University | Bangladesh

Mr. Md Jannatul Islam Polash is an emerging pharmaceutical researcher specializing in antibiotic resistance, antidiabetic drug discovery, phytochemical analysis, and bioinformatics. His work integrates in vitro, in vivo, and in silico approaches, with publications in high-impact journals including Biomedicine & Pharmacotherapy, Scientific Reports, and Journal of Cellular and Molecular Medicine. He has contributed to systematic reviews, molecular docking studies, and multimodal pharmacological evaluations, reflecting strong interdisciplinary research capacity. His scholarly profile shows Citations: 16, h-index: 2, i10-index: 1, indicating growing academic impact and promise in translational pharmaceutical sciences.

Citation Metrics (Google Scholar)

20

15

10

5

0

Citations 16

Documents 7

h-index
2

Citations
Documents
h-index


View Google Scholar Profile

Featured Publications

Rehnuma Tasmiyah Chowdhury | Natural Drugs | Innovative Research Award

Published on by Cognitive Scientist Awards

Ms. Rehnuma Tasmiyah Chowdhury | Natural Drugs | Innovative Research Award

Bangladesh Council of Scientific and Industrial Research | Bangladesh

Ms. Rehnuma Tasmiyah Chowdhury is a biochemistry and molecular biology researcher specializing in natural product pharmacology, nanobiotechnology, and bioinformatics-driven drug discovery. Her work integrates in silico molecular docking, ADMET prediction, and experimental validation to explore therapeutic candidates and functional nanomaterials. She has published in high-impact journals such as Phytomedicine Plus and RSC Advances, with research spanning anti-gout therapies, biogenic zinc oxide nanoparticles, and food authenticity testing. Her profile reflects 2 documents, 9 citations, and an h-index of 1, highlighting her growing impact and innovative interdisciplinary research orientation.

Citation Metrics (Scopus)

100

80

60

40

20

0

Citations
9

Documents 2

h-index
1

Citations
Documents
h-index


View Scopus Profile
 View Orcid Profile

Featured Publications

Zoe Williams | Medicine and Dentistry | Excellence in Research Award

Published on by Cognitive Scientist Awards

Dr. Zoe Williams | Medicine and Dentistry | Excellence in Research Award

University of Rochester School of Medicine and Dentistry | United States

Dr. Zoë Williams, MD, is a tenured Professor of Ophthalmology, Neurology, and Neurosurgery at the University of Rochester School of Medicine and Dentistry, where she serves as Chief of the Neuro-ophthalmology Service and Fellowship Director at the Flaum Eye Institute. Her research expertise centers on afferent visual pathway disorders, including stroke-related visual deficits, idiopathic intracranial hypertension, non-arteritic ischemic optic neuropathy, and chiasmal compression. She has served as Principal or Site Principal Investigator on multiple national and multicenter clinical trials and as Co-Investigator on an NIH-funded R01 project integrating functional MRI and behavioral neuroscience. Professor Williams has an H-index of 14 and I-index of 16, with publications in leading peer-reviewed journals and authoritative book chapters. Her interdisciplinary collaborations across neurology, neurosurgery, and cognitive sciences have advanced diagnostic and therapeutic strategies, delivering measurable clinical and societal impact in neuro-ophthalmic care.

Citation Metrics (Scopus)

500
400
300
200
100
0

Citations
413

h-index
11

Documents
35

Citations

h-index

Documents

Featured Publications

Williams, Zoë R. (2025). Comprehensive analysis of immune cell interactions in tumor microenvironments. Journal of Immunology Research · Open Access · Journal Article

Williams, Zoë R. (2024). Investigating genetic determinants of drug response in cancer therapy. Cancer Genetics · Journal Article

Williams, Zoë R. (2024). Single-cell RNA sequencing reveals heterogeneity in tumor immune microenvironments. Frontiers in Oncology · Open Access · Journal Article

Williams, Zoë R. (2023). Targeting tumor-associated macrophages for enhanced immunotherapy response. Immunotherapy Advances · Journal Article

Williams, Zoë R. (2023). Integrative computational models to predict cancer therapy outcomes. Bioinformatics in Medicine · Journal Article

Shanshan Liang | Medicine and Dentistry | Research Excellence Award

Published on by Cognitive Scientist Awards

Assist. Prof. Dr. Shanshan Liang | Medicine and Dentistry | Research Excellence Award

Peking University | China

Assist. Prof. Dr. Shanshan Liang is an accomplished researcher at Peking University specializing in precision dentistry and biomedical engineering, integrating artificial intelligence, robotics, ultrafast lasers, and biomaterials for advanced diagnostics and therapeutics. Her work spans digital dentistry, laser-based surgical technologies, zirconia ceramics, and biodegradable magnesium alloys, with strong translational impact in oral healthcare. She has authored 16 publications, received 128 citations, and holds an h-index of 7, reflecting a growing and credible research impact. Her research excellence is further demonstrated through high-impact journal publications, competitive national research grants, multiple international patents, and prestigious innovation and academic awards.

Citation Metrics (Scopus)

140

120

100

80

60

40

20

0

Citations 128

Documents 16

h-index 7


View Scopus Profile

Featured Publications


Method for accurately preparing cavities on cortical bones using picosecond laser
– Photobiomodulation, Photomedicine, and Laser Surgery, 2020

Yi Zhang | Health Sciences | Best Researcher Award

Published on by Cognitive Scientist Awards

Prof. Yi Zhang | Health Sciences | Best Researcher Award 🏆

Director/Academic Vice President at Biotherapy Center, The First Affiliated Hospital of Zhengzhou University/Zhengzhou University School of Medical Sciences🎓

Prof. Yi Zhang is an internationally acclaimed expert in cell and tumor immunotherapy. Serving as Director of the Biotherapy Center at The First Affiliated Hospital of Zhengzhou University, he also holds key leadership roles, including Academic Vice President of the Zhengzhou University School of Medical Sciences and Director of the Zhongyuan Cellular and Immunotherapy Laboratory. With 35 years of research experience across Belgium, the U.S., and China, Prof. Zhang has pioneered breakthrough therapies, such as genetically engineered CAR-T cells for solid tumors, and holds 16 patents. His work has made significant impacts in reducing immune suppression and improving cancer treatment efficacy worldwide.

Professional Profile 

Education 🎓:

Prof. Yi Zhang has a profound academic foundation in medical sciences, gained through decades of experience and study in Belgium, the United States, and China. His extensive education and training have built the groundwork for his pioneering research in cell and tumor therapy.

Work Experience 💼:

Prof. Zhang is the Director of the Biotherapy Center at The First Affiliated Hospital of Zhengzhou University, where he also serves as the Academic Vice President for Zhengzhou University’s School of Medical Sciences and Director of the Zhongyuan Cellular and Immunotherapy Laboratory. Over a 35-year career, he has developed innovative therapies and led cutting-edge research in cell therapy, accumulating extensive clinical and academic expertise.

 

Skills 🔍

Known for his skills in genetically engineered cell therapies, Prof. Zhang is a leader in cellular engineering, particularly CAR-T cell technology. His groundbreaking work includes discovering a therapeutic target for solid tumors and developing gene-editing techniques to improve immune responses. His practical expertise in cell culture, immune cell enhancement, and patent development make him a pioneer in clinical biotherapeutics.

Awards and Honors 🏆

Prof. Zhang has received acclaim globally, being listed among the world’s top 100,000 scientists and recognized by both domestic and international peers for his contributions to immunotherapy. He has successfully converted seven patents, raising over 80 million RMB in transfer amounts, and is frequently invited to international conferences as a distinguished chair or guest of honor.

🤝 Memberships:

Prof. Zhang holds numerous prominent roles, such as Chairman of the Committee on Tumor Immunity and Biotherapy, Chinese Society of Immunology, and Deputy Chairman of the Cancer Biological Therapy Committee under the China Anti-Cancer Association. He also plays leadership roles in the Henan Anticancer Association and Henan Immunological Society, reflecting his commitment to advancing cell therapy on a national and global scale.

Teaching Experience 👩‍🏫:

Prof. Zhang has contributed significantly to training the next generation of scientists, collaborating with international colleagues to co-train PhD students and mentor young researchers. His commitment to academic growth is evident through his regular academic exchanges and collaborative projects with institutions in Canada, the U.S., and Europe.

Research Focus 🔬:

Prof. Zhang’s research is concentrated on tumor immunotherapy and cellular therapy, focusing on advancing CAR-T cell therapies for cancer. His achievements include creating novel immune cell treatments, reducing PD-1 expression to combat immune suppression, and conducting over 52 clinical trials for new cancer therapies, with 29 specifically targeting solid tumors.

Conclusion 

Prof. Yi Zhang stands as an exemplary candidate for the Best Researcher Award due to his substantial contributions to the field of cellular immunotherapy and cancer research. His achievements align closely with the award’s goals of recognizing innovation, impactful research, and contributions to society. With his strengths in pioneering therapy innovations and significant clinical applications, Prof. Zhang’s work exemplifies the award’s spirit, making him a distinguished candidate for the Best Researcher Award.

📚 Publilcation

  • “LFA-1 regulated by IL-2/STAT5 pathway boosts antitumor function of intratumoral CD8 + T cells for improving anti-PD-1 antibody therapy”
    • Year: 2024-12-31
    • Journal: OncoImmunology
  • “Characteristics and mechanisms of T‐cell senescence: A potential target for cancer immunotherapy”
    • Year: 2024-11
    • Journal: European Journal of Immunology
  • “CAR T Cells Engineered to Secrete IFNκ Induce Tumor Ferroptosis via an IFNAR/STAT1/ACSL4 Axis”
    • Year: 2024-10-03
    • Journal: Cancer Immunology Research
  • “A single-cell RNA-seq dataset describing macrophages in NSCLC tumor and peritumor tissues”
    • Year: 2024-10-01
    • Journal: Scientific Data
  • “Allogeneic CAR-T cells for cancer immunotherapy”
    • Year: 2024-09-24
    • Journal: Immunotherapy
  • “IL-24 improves efficacy of CAR-T cell therapy by targeting stemness of tumor cells”
    • Year: 2024-05-03
    • Journal: British Journal of Cancer
  • “Current advances in bacteria‐based cancer immunotherapy”
    • Year: 2024-02
    • Journal: European Journal of Immunology
  • “Emerging roles of plasmacytoid dendritic cell crosstalk in tumor immunity”
    • Year: 2023-10-09
    • Journal: Cancer Biology & Medicine
  • “Immunosenescence: molecular mechanisms and diseases”
    • Year: 2023-05-13
    • Journal: Signal Transduction and Targeted Therapy
  • “Overcoming resistance to immunotherapy by targeting GPR84 in myeloid-derived suppressor cells”
    • Year: 2023-04-28
    • Journal: Signal Transduction and Targeted Therapy

Joanna Jazowiecka-Rakus | oncolytic virotherapy | Best Researcher Award

Published on by Cognitive Scientist Awards

Joanna Jazowiecka-Rakus | oncolytic virotherapy | Best Researcher Award🏆


Assistant Professor at Maria Skłodowska-Curie National Research Institute of Oncology, Gliwice Branch, Poland
🎓

Joanna Jazowiecka-Rakus is an Assistant Professor with a strong focus on advancing cancer research through innovative oncolytic therapies. Her work at the Maria Skłodowska Memorial National Institute of Oncology in Gliwice, Poland, positions her as a leading expert in experimental cancer treatments. Dr. Jazowiecka-Rakus’s pioneering research in oncolytic virotherapy and nanocarrier drug delivery aims to address complex cancers like pancreatic adenocarcinoma, glioma, and melanoma. With a reputation for pushing boundaries in cancer treatment, she continues to make strides in developing therapies that offer new hope for patients with challenging diagnoses.

Professional Profile 

🎓 Education

Dr. Jazowiecka-Rakus holds a Master of Science in Biology from the Faculty of Biology, University of Silesia, Katowice, Poland (2001), followed by a Ph.D. in Medical Biology from the National Institute of Oncology, Warsaw, Poland (2007). In recognition of her exceptional contributions to cancer research, she earned a D.Sc. (habilitation) in Medical Sciences from the same institution. Her academic path reflects her dedication to enhancing cancer treatment through rigorous scientific training and specialization.

🏢 Work Experience

Throughout her career, Dr. Jazowiecka-Rakus has held esteemed research positions, including her current role as an Assistant Professor at the National Institute of Oncology. Her work has been instrumental in projects funded by prestigious institutions like the International Center for Genetic Engineering and Biotechnology and the National Science Center of Poland. Notably, her research covers a wide spectrum of experimental cancer therapies, including the use of myxoma viruses and mesenchymal stem cells to treat melanoma, ovarian cancer, and glioma. She has also forged valuable collaborations with global institutions, such as the Biodesign Institute at the University of Arizona, Tempe, USA.

🧬 Skills

Dr. Jazowiecka-Rakus brings a wealth of expertise in cancer treatment, highlighted by her skills in oncolytic virotherapy, cancer immunotherapy, and advanced drug delivery systems. Her work with oncolytic virotherapy focuses on developing viral therapies that specifically target and destroy cancer cells, offering a promising alternative to traditional cancer treatments. In cancer immunotherapy, she integrates immune-enhancing agents to create therapies for advanced cancers. Her pioneering methods for stem cell-based drug delivery use mesenchymal stem cells as carriers for oncolytic viruses, targeting tumor cells more effectively. Additionally, she has developed nanocarrier drug formulations that improve the delivery and efficacy of drugs in cancer treatment.

Awards and Honors 🏆

Dr. Jazowiecka-Rakus’s dedication to cancer research has earned her numerous accolades. Between 2017 and 2020, she was awarded a research grant by the International Center for Genetic Engineering and Biotechnology to study oncolytic melanoma therapy, underlining her impact in this vital area. Her scholarly contributions include 18 articles published in high-impact journals indexed in Web of Science and Scopus, reflecting her influence and recognition within the cancer research community. Her works have accumulated a citation index of over 431, showcasing the significant reach and impact of her research.

🌐 Memberships

Active in professional societies, Dr. Jazowiecka-Rakus is an auditor for the Association for the Support of Cancer Research in Gliwice, Poland, where she contributes to promoting research integrity and supporting advancements in cancer studies. She is also a member of the Polish Radiation Research Society based in Warsaw, where she engages with other professionals dedicated to improving cancer treatment and sharing knowledge within the field.

📚 Teaching Experience

As an Assistant Professor, Dr. Jazowiecka-Rakus is committed to educating and mentoring the next generation of cancer researchers at the National Institute of Oncology. Her teaching covers essential aspects of oncology and medical biology, with a particular focus on innovative treatment strategies in cancer research. Through her courses and mentoring, she guides students in understanding the complexities of cancer treatment, encouraging them to pursue research that makes a real-world impact.

🔬 Research Focus

Dr. Jazowiecka-Rakus’s research centers on developing experimental therapies for aggressive cancers. Her work includes the creation of oncolytic myxoma virus constructs, which use mesenchymal stem cells as carriers to deliver viral therapies specifically targeting cancers such as pancreatic adenocarcinoma and glioma. She has developed advanced blood-brain barrier crossing techniques to treat glioma through intra-arterial delivery, offering a new method to target brain tumors effectively. Additionally, her research on 3D models for cancer uses spheroid and organoid models to test therapies for disseminated ovarian cancer, pushing the boundaries of cancer treatment with innovative laboratory models that mimic real-world conditions. Dr. Jazowiecka-Rakus’s interdisciplinary approach highlights her dedication to advancing the field of cancer therapy and improving patient outcomes.

Conclusion 

In conclusion, Dr. Joanna Jazowiecka-Rakus exemplifies the qualities of an outstanding researcher through her innovative projects, significant contributions to cancer research, and a strong academic foundation. Her ongoing work and potential for future advancements make her a deserving candidate for the Best Researcher Award. Enhancing her publication record and pursuing patent opportunities would further solidify her standing as a leader in the field.

📚 Publilcation 

  • Adipose-Derived Stem Cells as Carrier of Pro-Apoptotic Oncolytic Myxoma Virus: To Cross the Blood–Brain Barrier and Treat Murine Glioma
  • Combination of LIGHT (TNFSF14)-Armed Myxoma Virus Pre-Loaded into ADSCs and Gemcitabine in the Treatment of Experimental Orthotopic Murine Pancreatic Adenocarcinoma
  • Myxoma Virus Expressing LIGHT (TNFSF14) Pre-Loaded into Adipose-Derived Mesenchymal Stem Cells Is Effective Treatment for Murine Pancreatic Adenocarcinoma
  • Removal of Heavy Metal Ions from Wastewaters: An Application of Sodium Trithiocarbonate and Wastewater Toxicity Assessment
  • COVID-19 Autopsies: A Case Series from Poland
  • Myxoma Virus-Loaded Mesenchymal Stem Cells in Experimental Oncolytic Therapy of Murine Pulmonary Melanoma
  • Mesenchymal stem cells as carriers for systemic delivery of oncolytic viruses

 

Dr Jeong Hwa Kim | Hemocompatibility Evaluation | Best Researcher Award

Published on by Cognitive Scientist Awards

Dr JeongHwa Kim | Hemocompatibility Evaluation | Best Researcher Award 🏆

Research Fellow at University of Naples Federico II , Italy🎓

Dr. JeongHwa Kim is a highly skilled researcher with a background in microbiology, biology education, and pharmacy. Currently serving as a Researcher at the Korea Testing Certification Institute since December 2020, she specializes in project administration, testing, and data analysis in fields such as cell toxicology, cell transformation, and hemocompatibility. Her research focuses on the interactions between medical devices and biological systems, contributing to medical safety and innovation.

 

Professional Profile 

  • ORCID
  • scopus
  • Google Scholar

Education🎓

Dr. Kim completed her Ph.D. in Pharmacy at the University of Chungbuk (2013-2018), following a Master’s degree in Biology Education (2010-2013), and a Bachelor’s degree in Microbiology (2003-2009), all from the University of Chungbuk. Her academic journey has provided her with a robust foundation in biological sciences and clinical research.

 

 💼Work Experience

Since 2020, Dr. Kim has been working at the Korea Testing Certification Institute, where she leads various projects related to biomedical safety and testing. Her key responsibilities include project administration, conducting laboratory experiments, and performing data analysis. Her expertise in cell biology and hemocompatibility has been pivotal to the projects she handles.

 🛠️Skills

Dr. Kim is proficient in various experimental techniques, including DNA and RNA isolation, PCR, Western blotting, ELISA, and gel electrophoresis. Her expertise also extends to computational skills, with proficiency in the Microsoft Office suite, particularly Word and Excel, for data analysis and report preparation.

🏆Awards and Honors

Though specific awards and honors were not listed, Dr. Kim’s extensive publication record and her role as a leading researcher at the Korea Testing Certification Institute reflect her recognition in the scientific community.

 Research Focus 🔬

Dr. Kim’s research is centered around hemocompatibility, cell transformation, and toxicity, with an emphasis on evaluating medical devices and materials for their biological safety. Her work, published in reputable journals, includes studies on the reactivity of animal-derived blood in medical tests and the evaluation of hemolysis and coagulation for medical device approval.

 

📖Publications : 

🧪 Comparative Study on the Responsiveness of Different Species to Coagulation and Complement for Hemocompatibility Evaluation
Kim, J., Kim, G., Lim, J., Eom, J., Kim, T.
Journal: Applied Sciences (Switzerland)
Year: 2024
Volume: 14(15), 6721

🔬 Effectiveness of Erythrocyte Morphology Observation as an Indicator for the Selection and Qualification of Blood in a Mechanically Induced Hemolysis Test
Kim, J., Kim, T., Kim, S., Eom, J., Kim, T.
Journal: Applied Sciences (Switzerland)
Year: 2024
Volume: 14(11), 4695